- Bone Health
- Immunology
- Hematology
- Respiratory
- Dermatology
- Diabetes
- Gastroenterology
- Neurology
- Oncology
- Ophthalmology
- Rare Disease
- Rheumatology
"Not So Different" Episode 4: Creating a Vibrant Biosimilars Marketplace
“We need all stakeholders to be all in on biosimilars…now’s the time for people to get engaged and get out there to support uptake and access,” says our guest, Juliana Reed, president of Biosimilars Forum.
Last week on the podcast, we brought you an industry perspective on biosimilars with a discussion of how manufacturers think about pricing their products for the marketplace. This week, we’re changing gears with a discussion of how that marketplace is working.
Our guest this week is Juliana Reed, president of Biosimilars Forum.
The Biosimilars Forum is a nonprofit organization that seeks to raise awareness of biosimilars and provide an opportunity for developers to work together with other stakeholders on relevant topics in the industry. The founding members of the Biosimilars Forum include many of the companies with significant US biosimilar development portfolios.
Reed joined The Center for Biosimilars® by phone to discuss reimbursement, policy, and what it takes to create a vibrant marketplace for cost-saving biosimilars.
How AI Can Help Address Cost-Related Nonadherence to Biologic, Biosimilar Treatment
March 9th 2025Despite saving billions, biosimilars still account for only a small share of the biologics market—what's standing in the way of broader adoption and how can artificial intelligence (AI) help change that?
Biosimilars in Action: Market Shifts, Legal Insights, and FDA Approvals
February 9th 2025In this episode of Not So Different, host Skylar Jeremias covers the latest biosimilar developments, including new FDA approvals, patent disputes, and biosimilar market trends shaping the health care landscape.
Biosimilars Policy Roundup for March 2023—Podcast Edition
April 2nd 2023On this episode of Not So Different, we discuss some of the global biosimilar policy news that came out during the month of March, including a new bill in Congress and 2 Canadian jurisdictions implementing switching policies.
Biosimilars Gastroenterology Roundup for February 2023—Podcast Edition
March 5th 2023On this episode of Not So Different, we chronicle the latest gastroenterology news from February, including several updates on adalimumab and infliximab biosimilars and industry analyses on the utilization of these drugs and patient confidence in gastroenterologists’ recommendations.
